Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE ® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism October 1, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Group 1 Automotive Appoints Mark Raban as CEO of U.K. Operations Back: All Posts Next:WISeKey's Extensive Expertise Lays the Foundation for the Development of a Semiconductor Manufacturing Project in Switzerland